Literature DB >> 16207588

Dyskeratosis congenita: a disorder of defective telomere maintenance?

Amanda J Walne1, Anna Marrone, Inderjeet Dokal.   

Abstract

Dyskeratosis congenita (DC) is a rare multisystem bone marrow failure syndrome that displays marked clinical and genetic heterogeneity. X-linked recessive, autosomal dominant and autosomal recessive forms of the disease are recognized. The gene that is mutated in the X-linked form of the disease is DKC1. The DKC1-encoded protein, dyskerin, is a component of small nucleolar ribonucleoprotein particles, which are important in ribosomal RNA processing, and of the telomerase complex. The autosomal dominant form of DC is due to mutations in the gene for the RNA component of telomerase (TERC). Because both dyskerin and TERC are components of the telomerase complex and all patients with DC have short telomeres, the principal pathology of DC appears to relate to telomerase dysfunction, although defects in ribosomal processing via dyskerin's involvement in pseudouridylation cannot be completely ruled out. The gene or genes involved in autosomal recessive DC remain elusive, although genes whose products are required for telomere maintenance remain strong candidates. The study of DC highlights the importance of telomerase in humans and how its deficiency results in multiple abnormalities, including premature aging, bone marrow failure, and cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207588     DOI: 10.1532/IJH97.05067

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  63 in total

Review 1.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

Review 2.  Biogenesis of small nucleolar ribonucleoproteins.

Authors:  Witold Filipowicz; Vanda Pogacić
Journal:  Curr Opin Cell Biol       Date:  2002-06       Impact factor: 8.382

3.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.

Authors:  Tom Vulliamy; Anna Marrone; Richard Szydlo; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Nat Genet       Date:  2004-04-18       Impact factor: 38.330

4.  Function, replication and structure of the mammalian telomere.

Authors:  Dominique Broccoli
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

5.  Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.

Authors:  Hiroki Yamaguchi; Gabriela M Baerlocher; Peter M Lansdorp; Stephen J Chanock; Olga Nunez; Elaine Sloand; Neal S Young
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

6.  The box H + ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase.

Authors:  D L Lafontaine; C Bousquet-Antonelli; Y Henry; M Caizergues-Ferrer; D Tollervey
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

7.  Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.

Authors:  Maria Antonietta Cerone; Ryan J Ward; J Arturo Londoño-Vallejo; Chantal Autexier
Journal:  Cell Cycle       Date:  2005-04-03       Impact factor: 4.534

8.  Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.

Authors:  Patrick F Fogarty; Hiroki Yamaguchi; Adrian Wiestner; Gabriela M Baerlocher; Elaine Sloand; Weihua S Zeng; Elizabeth J Read; Peter M Lansdorp; Neal S Young
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321

Review 9.  Telomere repeat binding factors: keeping the ends in check.

Authors:  Jan Karlseder
Journal:  Cancer Lett       Date:  2003-05-15       Impact factor: 8.679

10.  NAP57, a mammalian nucleolar protein with a putative homolog in yeast and bacteria.

Authors:  U T Meier; G Blobel
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  19 in total

1.  Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancers.

Authors:  Ian M Smith; Suhail K Mithani; Wojciech K Mydlarz; Steven S Chang; Joseph A Califano
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2010-03-24       Impact factor: 1.538

Review 2.  The biogenesis and regulation of telomerase holoenzymes.

Authors:  Kathleen Collins
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

3.  Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita.

Authors:  Judy M Y Wong; Kathleen Collins
Journal:  Genes Dev       Date:  2006-10-02       Impact factor: 11.361

4.  Dyskeratosis congenita- management and review of complications: a case report.

Authors:  Shivam Sinha; Vikas Trivedi; Arvind Krishna; Nidhi Rao
Journal:  Oman Med J       Date:  2013-07

Review 5.  Recent progress in dyskeratosis congenita.

Authors:  Nobuhiro Nishio; Seiji Kojima
Journal:  Int J Hematol       Date:  2010-10-01       Impact factor: 2.490

Review 6.  The role of telomere biology in bone marrow failure and other disorders.

Authors:  Sharon A Savage; Blanche P Alter
Journal:  Mech Ageing Dev       Date:  2007-11-19       Impact factor: 5.432

7.  Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.

Authors:  Anna Marrone; Amanda Walne; Hannah Tamary; Yuka Masunari; Michael Kirwan; Richard Beswick; Tom Vulliamy; Inderjeet Dokal
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

8.  Slow growth and unstable ribosomal RNA lacking pseudouridine in mouse embryonic fibroblast cells expressing catalytically inactive dyskerin.

Authors:  Bai-Wei Gu; Jingping Ge; Jian-Meng Fan; Monica Bessler; Philip J Mason
Journal:  FEBS Lett       Date:  2013-05-28       Impact factor: 4.124

9.  Dyskeratosis congenita: the first NIH clinical research workshop.

Authors:  Sharon A Savage; Inderjeet Dokal; Mary Armanios; Geraldine Aubert; Edward W Cowen; Demetrio L Domingo; Neelam Giri; Mark H Greene; Paul J Orchard; Jakub Tolar; Ekaterini Tsilou; Carter Van Waes; Judy M Y Wong; Neal S Young; Blanche P Alter
Journal:  Pediatr Blood Cancer       Date:  2009-09       Impact factor: 3.167

10.  TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.

Authors:  Sharon A Savage; Neelam Giri; Gabriela M Baerlocher; Nick Orr; Peter M Lansdorp; Blanche P Alter
Journal:  Am J Hum Genet       Date:  2008-01-31       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.